Actinic Keratosis

A phase 3 study of Ameluz and RhodoLED photodynamic therapy for superficial basal cell carcinoma has reached a key milestone as the final patient has completed the 1-year follow-up visit, Biofrontera announced in a press release.

The FDA has approved the supplemental new drug application for Ameluz topical gel 10% to increase the maximal dosage from one to three tubes per treatment of actinic keratosis, according to a Biofrontera press release.

The FDA has approved the expanded use area of Klisyri to up to 100 cm2 on the face and scalp for the treatment of actinic keratosis, Almirall announced in a press release.

Actinic keratosis lesions were reduced and quality of life improved following once-daily topical tirbanibulin treatment, according to a study.

The supplemental new drug application for Ameluz has received a “no filing review issues identified” letter from the FDA, according to a press release.

While most Mohs surgeons agree on diagnostic differentiations between actinic keratosis and squamous cell carcinoma in situ, variability exists in the interpretation of in situ carcinoma on histological frozen sections, according to a study.

Nicotinamide therapy was not effective in lowering the rates of keratinocyte cancers or actinic keratoses in immunosuppressed solid-organ transplant recipients, according to a phase 3 trial.

Due to the lack of clarity in literature, widespread implementation of consensus recommendations for actinic keratoses and cutaneous squamous cell carcinoma is needed, according to a study.

MIAMI BEACH, Fla. — Emerging treatments for actinic keratosis promise a brighter future for patients as phase 2 trials show high efficacy rates, according to a presenter at South Beach Symposium.

WAILEA, Hawaii — The treatment of actinic keratosis can be challenging. At the Maui Derm meeting, George M. Martin, MD, meeting founder and program director, and Ted Rosen, MD, gave an update on treatment options.